Evidence map›Paper›PMID 34538991›Full record

ArticlePattern recognition letters2021

Prediction on transmission trajectory of COVID-19 based on particle swarm algorithm.

Caichang Ding, Yiqin Chen, Zhiyuan Liu, Tianyin Liu

Abstract read
In one paragraph

Article in Pattern recognition letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A new hybrid prediction model of COVID-19 daily new case data.Engineering applications of artificial intelligence · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Caichang DingSchool of Computer Science, Hubei Polytechnic University, Huangshi 435003, China.
Yiqin ChenSchool of Electronic and Optical Engineering, Nanjing University of Science and Technology, Nanjing 210094, China.
Zhiyuan LiuSchool of Computer Science, Hubei Polytechnic University, Huangshi 435003, China.
Tianyin LiuSchool of Computer Science, Hubei Polytechnic University, Huangshi 435003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to predict the transmission trajectory of the 2019 Corona Virus Disease (COVID-19). The particle swarm optimization (PSO) algorithm was combined with the traditional susceptible exposed infected recovered (SEIR) infectious disease prediction model to propose a SEIR-PSO prediction model on the COVID-19. In addition, the domestic epidemic data from February 25, 2020 to March 20, 2020 in China were selected as the training set for analysis. The results showed that when the conversion rate, recovery rate, and mortality rate of the SEIR-PSO model were 1/5, 1/15, and 1/13, its predictive effect on the number of people diagnosed with COVID-19 was the closest to the real data; and the SEIR-PSO model showed a mean-square errors (MSE) value of 1304.35 and mean absolute error (MAE) value of 1069.18, showing the best prediction effect compared with the susceptible infectious susceptible (SIS) model and the SEIR model. In contrary to the standard particle swarm optimization (SPSO) and linear weighted particle swarm optimization (LPSO), which were two classical improved PSO algorithms, the reliability and diversity of the SEIR-PSO model were higher. In summary, the SEIR-PSO model showed excellent performance in predicting the time series of COVID-19 epidemic data, and showed reliable application value for the prevention and control of COVID-19 epidemic.

Indexed as

2019 Corona virus diseaseParticle swarm optimizationPrediction of infectious diseaseSusceptible exposed infected recovered model

Identifiers

PMID34538991
PMCPMC8440343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.